javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited14.246718844533.9050
Domestic EquitiesDivi's Laboratories Limited8.43173009820.0663
Domestic EquitiesApollo Hospitals Enterprise Limited6.19531803214.7439
Domestic EquitiesLaurus Labs Limited5.06438848912.0522
Domestic EquitiesTorrent Pharmaceuticals Limited4.90152644611.6648
Domestic EquitiesMax Healthcare Institute Limited4.895612072111.6508
Domestic EquitiesAurobindo Pharma Limited4.27987140610.1854
Domestic EquitiesDr. Reddy's Laboratories Limited3.9760725929.4624
Domestic EquitiesLupin Limited3.5270370148.3937
Domestic EquitiesCipla Limited3.4208581088.1409
Domestic EquitiesFortis Healthcare Limited3.0224774717.1928
Domestic EquitiesNeuland Laboratories Limited3.004941857.1513
Domestic EquitiesAlkem Laboratories Limited2.8769124536.8467
Domestic EquitiesCohance Lifesciences Limited2.65211462716.3116
Domestic EquitiesAbbott India Limited2.031218004.8339
Domestic EquitiesMankind Pharma Limited1.9494195294.6393
Domestic EquitiesAster DM Healthcare Limited1.7875584044.2539
Domestic EquitiesSai Life Sciences Limited1.6293334263.8774
Domestic EquitiesShaily Engineering Plastics Limited1.4693116973.4968
Domestic EquitiesIPCA Laboratories Limited1.4405224883.4281
Domestic EquitiesLinde India Limited1.300242953.0943
Domestic EquitiesBiocon Limited1.2618700543.0029
Domestic EquitiesPiramal Pharma Limited1.23541701522.9401
Domestic EquitiesGlenmark Pharmaceuticals Limited1.2271128372.9203
Domestic EquitiesSBI Life Insurance Company Limited1.2247159262.9146
Domestic EquitiesHealthcare Global Enterprises Limited1.1691436612.7823
Domestic EquitiesJubilant Ingrevia Limited1.1155410812.6547
Domestic EquitiesRainbow Childrens Medicare Limited1.0528181522.5055
Domestic EquitiesShilpa Medicare Limited1.0392495682.4732
Domestic EquitiesSupriya Lifescience Limited1.0327253702.4576
Domestic EquitiesPark Medi World Limited1.0199841212.4272
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.855692132.0363
Domestic EquitiesVenus Pipes And Tubes Limited0.8137138521.9365
Domestic EquitiesZydus Lifesciences Limited0.7604167921.8097
Domestic EquitiesPoly Medicure Limited0.6831120441.6256
Domestic EquitiesYes Bank Limited0.51435287251.2240
Domestic EquitiesCaplin Point Laboratories Limited0.483556841.1507
Domestic EquitiesSyngene International Limited0.4144223150.9863
Total 98.0057 233.2390
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)1.9943 4.7462
Total 1.9943 4.7462
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.